Sibanye-Stillwater and Necsa target next-gen precision cancer therapies with rhodium
Link to News Siphelele Dludla|Published 2 April South African miner Sibanye-Stillwater and the South African Nuclear Energy Corporation (Necsa) will collaborate to further research the radioactive rhodium-based palladium isotope, with the aim of applying it in cancer therapy. “This collaboration brings together complementary strengths to advance research in nuclear medicine,…








